Price $24.38 |
Market Cap
211.6M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
8.92
|
P/S
5.57
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-4.2K
|
FCF
-0.5
|
|
Op. Margin
-18.10%
|
Net Margin
-18.10%
|
ROE
-28.30%
|
ROI
-27.10%
|
|
ROA
-23.10%
|
EPS Growth
10.20%
|
Current Ratio
5.2
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Streamline Health Solutions In (STRM) | $1.80 | - | - | 26.4M | Strong Buy |
| Harvard Bioscience, Inc. (HBIO) | $2.10 | - | - | 87.4M | Strong Buy |
| ImmuCell Corporation (ICCC) | $6.70 | - | - | 44.5M | Strong Buy |
| Premier Inc (PINC) | $37.24 | - | - | 4.68B | Strong Buy |
| Bausch Health Companies Inc (BHC) | $22.00 | - | - | 7.55B | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
